Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors

dc.contributor.authorNavarro Brugal, Gemma
dc.contributor.authorAymerich, María Soledad
dc.contributor.authorMarcellino, Daniel
dc.contributor.authorCortés Tejedor, Antonio
dc.contributor.authorCasadó, Vicent
dc.contributor.authorMallol Montero, Josefa
dc.contributor.authorCanela Campos, Enric I. (Enric Isidre), 1949-
dc.contributor.authorAgnati, Luigi F.
dc.contributor.authorWoods, Amina S.
dc.contributor.authorFuxe, Kjell
dc.contributor.authorLluís i Biset, Carme
dc.contributor.authorLanciego, José Luis
dc.contributor.authorFerré, Sergi
dc.contributor.authorFranco Fernández, Rafael
dc.date.accessioned2018-05-18T14:39:21Z
dc.date.available2018-05-18T14:39:21Z
dc.date.issued2009-10-09
dc.date.updated2018-05-18T14:39:21Z
dc.description.abstractThe Ca2+-binding protein calmodulin (CaM) has been shown to bind directly to cytoplasmic domains of some G protein-coupled receptors, including the dopamine D2 receptor. CaM binds to the N-terminal portion of the long third intracellular loop of the D2 receptor, within an Arg-rich epitope that is also involved in the binding to Gi/o proteins and to the adenosine A2A receptor, with the formation of A2A-D2 receptor heteromers. In the present work, by using proteomics and bioluminescence resonance energy transfer (BRET) techniques, we provide evidence for the binding of CaM to the A2A receptor. By using BRET and sequential resonance energy transfer techniques, evidence was obtained for CaM-A2A-D2 receptor oligomerization. BRET competition experiments indicated that, in the A2A-D2 receptor heteromer, CaM binds preferentially to a proximal C terminus epitope of the A2A receptor. Furthermore, Ca2+ was found to induce conformational changes in the CaM-A2A-D2 receptor oligomer and to selectively modulate A2A and D2 receptor-mediated MAPK signaling in the A2A-D2 receptor heteromer. These results may have implications for basal ganglia disorders, since A2A-D2 receptor heteromers are being considered as a target for anti-parkinsonian agents.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec573504
dc.identifier.issn0021-9258
dc.identifier.pmid19632986
dc.identifier.urihttps://hdl.handle.net/2445/122461
dc.language.isoeng
dc.publisherAmerican Society for Biochemistry and Molecular Biology
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1074/jbc.M109.034231
dc.relation.ispartofJournal of Biological Chemistry, 2009, vol. 284, num. 41, p. 28058-28068
dc.relation.urihttps://doi.org/10.1074/jbc.M109.034231
dc.rights(c) American Society for Biochemistry and Molecular Biology, 2009
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Bioquímica i Biomedicina Molecular)
dc.subject.classificationAdenosina
dc.subject.classificationProteïnes
dc.subject.otherAdenosine
dc.subject.otherProteins
dc.titleInteractions between calmodulin, adenosine A2A, and dopamine D2 receptors
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
573504.pdf
Mida:
2.75 MB
Format:
Adobe Portable Document Format